Breast Cancer Screening in Women With Multiple Sclerosis: A Mixed‐Methods Study

Documenti analoghi

• A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple Sclerosis
  di: Camilla Maersk‐Moller, et al.
  Pubblicazione: (2026)
• Erythrocyte Fragility in Progressive Multiple Sclerosis
  di: Carmen Jacob, et al.
  Pubblicazione: (2026)
• De‐Escalation of Disease‐Modifying Therapy in Multiple Sclerosis—A Danish Nationwide Cohort Study
  di: Frederik Elberling, et al.
  Pubblicazione: (2025)
• Differences in Income Growth Between People With Multiple Sclerosis and Controls: A Norwegian Cohort Study
  di: Anne Høgset, et al.
  Pubblicazione: (2026)
• Reasons for Healthcare Use Before Onset of Multiple Sclerosis: A Nationwide Matched Cohort Study in Sweden
  di: Ali Manouchehrinia, et al.
  Pubblicazione: (2025)